The primary research center for BPC-157 is the Department of Pharmacology at the University of Zagreb, led by Professor Predrag Sikiric
Testimonials indicate that these peptides may support rehabilitation, particularly for athletes and individuals recovering from surgery or injury
Not a medicine, food, cosmetic, or dietary supplement
Intramuscular injections (often into the thigh or upper arm) ensure your body gets the full benefit without any loss
BPC-157 operates through growth hormone receptor upregulation, NO-synthase pathway activation, and FAK-paxillin signalling , producing cytoprotective, anti-inflammatory, and growth factor-mediated repair effects particularly pronounced in gastrointestinal, tendon, and neurological tissue
En Estados Unidos: La FDA no ha aprobado el BPC-157 para uso teraputico